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Abstract Pyruvate dehydrogenase (PDH) deficiency is one
of the most common causes of congenital lactic acidosis.
Correlations between the genetic defect and neuroimaging
findings are lacking. We present conventional and diffu-
sion-weighted MRI findings in a 7-day-old male neonate
with PDH deficiency due to a mosaicism for the R302H
mutation in the PDHA1 gene. Corpus callosum dysgenesis,
widespread increased diffusion in the white matter, and
bilateral subependymal cysts were the main features.
Although confirmation of PDH deficiency depends on
specialized biochemical analyses, neonatal MRI plays a
role in evaluating the pattern and extent of brain damage,
and potentially in early diagnosis and clinical decision
making.
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Introduction
Pyruvate dehydrogenase (PDH) deficiency results from
mutations in the mitochondrial PDH complex, an important
enzyme for mitochondrial energy metabolism. In 90% of
patients the abnormality occurs in the X-linked gene for the
E1-α subunit (PDHA1 gene) [1]. Neonatal presentation
with lactic acidosis is most common [2]. Although
confirmation of the diagnosis depends on specialized
biochemical analyses, neonatal neuroimaging plays a role
in the evaluation of brain damage and abnormalities. We
describe the conventional and diffusion-weighted (DW)
MRI findings in a 7-day-old male infant with PDH
deficiency due to mosaicism for the R302H mutation in
the PDHA1 gene. Imaging correlations at 18 months of age
are provided. Potential injury mechanisms, and the diag-
nostic and clinical decision-making value of the neuro-
imaging findings are discussed.
Case report
The patient was a male infant, born at 38 weeks’ gestation
to a 16-year-old primigravid Caucasian mother; the parents
were nonconsanguineous. Prenatal US screening was not
performed. His birth weight was 3,180 g and his head
circumference was on the 25th centile. He was admitted to
the neonatal intensive care unit after birth because of
respiratory distress. His face was mildly dysmorphic, with
hypertelorism, a long nasal philtrum, and anteverted
nostrils. Initial neurological examination revealed absent
swallowing reflex, exaggerated Moro reflex, and axial
hypotonia.
On admission, elevated plasma lactate (8.09 mmol/l;
normal range, NR, 0.63–2.44 mmol/l) and pyruvate
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(339 μmol/l; NR 54.1–119.9 μmol/l) levels, with a normal
lactate/pyruvate ratio, were found. Subsequently, elevated
cerebrospinal fluid lactate (6.6 mmol/l; NR 1.2–2.1 mmol/l)
and alanine (95 μmol/l; NR 13.8–32.6 μmol/l) levels were
also demonstrated.
MRI at 7 days of age showed colpocephaly, dysgenesis
of the corpus callosum, prominent bilateral germinolytic
cysts in the caudothalamic groove and lateral ventricles,
and widespread T1 and T2 prolongation of the white
matter with cystic change in the anterior temporal lobes
(Fig. 1). A few punctate high-signal lesions were found
bilaterally in the basal ganglia on T2-weighted (T2-W)
images. No cortical malformations were detected and
myelination was appropriate for gestational age. The
cerebellum appeared normal. In addition, widespread
increased diffusion was detected in the white matter on
DW images and ADC maps. MR spectroscopy (MRS;
region of interest positioned in the left centrum semiovale,
TE 135 ms; not shown) demonstrated a lactate doublet at
1.33 ppm, but failed to reveal a pyruvate peak at 2.37 ppm.
Fibroblast biochemical analysis confirmed significantly
decreased PDH activity. Mutation analysis detected mosa-
icism for the R302H mutation in the PDHA1 gene. No
specific treatment was started.
At 18 months of age, the child demonstrated microceph-
aly and severe neurodevelopmental delay with a total
absence of response to visual or auditory stimuli. MR
images showed severe atrophy of the white matter and
corpus callosum (Fig. 2). White matter signal intensity was
normal on T1-W and T2-W images.
Fig. 1 Brain MRI at 7 days of
age. a Mid-sagittal T1-W spin-
echo (TR/TE 624/15 ms) image
demonstrates dysgenesis of the
corpus callosum. Note thicken-
ing of the genu and anterior
body while the mid- and poste-
rior body are very thin. There is
agenesis of the splenium and
rostrum. b Coronal T1-W spin-
echo image demonstrates
subependymal cysts in the right
lateral ventricle and left caudo-
thalamic groove. Also note nor-
mal myelination (hyperintensity)
in the posterior limb of the
internal capsule and widespread
hypointensity of the white mat-
ter. c Axial T2-W turbo spin-
echo (TR/TE 3,000/120 ms)
image shows enlarged and
mildly colpocephalic lateral
ventricles and widespread white
matter hyperintensity. d ADC
map reveals bilaterally increased
water diffusion in the white
matter, particularly in the tem-
poral lobes
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Discussion
PDH is a key mitochondrial enzyme complex in the
oxidative carboxylation of pyruvate to acetyl-CoA, control-
ling the flow of substrate entering the Krebs cycle [1, 2]. In
neonates, recognition of PDH deficiency is difficult due to
the wide variety of clinical presentations that depend on the
particular mutation and the residual PDH complex activity.
Poor feeding, lethargy, hypotonia, and respiratory distress
are nonspecific signs that may point in the direction of a
metabolic disorder. Lactic acidosis and normal lactate/
pyruvate ratios are more characteristic findings. Decreased
PDH complex activity confirms the diagnosis, but the bio-
chemical studies may take weeks to months to complete.
Brain MRI forms part of the investigation of metabolic
disorders, including neonatal PDH deficiency. Convention-
al MRI features of PDH deficiency have been previously
described [1–5], and include enlarged ventricles, cerebral
and cerebellar white matter involvement (including cystic
change), brainstem atrophy, absence of medullary pyra-
mids, abnormal inferior olives, cerebellar dysplasia, partial
or complete agenesis of the corpus callosum, and basal
ganglia hyperintensities on T2-W images. To our knowl-
edge, this is the first report of conventional MRI and DW
imaging findings in a male neonate. The gender differen-
tiation is of importance because E1-α deficiency is
associated with various types of brain damage and
significant differences in symptoms have been described
between female and male patients; for example, infantile
spasms have been encountered almost exclusively in
females [3].
In the infant presented here, diffuse and widespread
white matter involvement presented with T1 hypointensity
and T2 hyperintensity on conventional images, and in-
creased signal intensity on ADC maps. Elevated ADC
values (i.e. an increase in water content and a decrease in
restriction of water diffusion) are suggestive of diffuse
white matter abnormality (vasogenic oedema or encepha-
lomalacia), and may be predictive of progressive atrophy.
Occasionally, infants with a metabolic disorder may be
suspected of hypoxic-ischaemic encephalopathy (HIE). In
HIE, white matter injury, occurring as a consequence of a
hypoxic-ischaemic insult, may present with similar con-
ventional and DW imaging findings and evolution [6]. In
metabolic disorders, however, the basal ganglia abnormal-
ities tend to be more focal and punctate and mostly do not
evolve [7]. HIE is an important differential diagnosis to
consider since implications for medicolegal proceedings
and genetic counselling can be considerable. Thus, al-
though nonspecific, diffuse white matter involvement,
demonstrated by conventional MRI and DW imaging,
may be of prognostic value.
Corpus callosum dysgenesis can be identified in prenatal
life by US and fetal MRI, and is relevant for the differential
diagnosis with HIE, indicating a disease onset during the
first half of gestation. Callosal malformations have been
previously reported in PDH deficiency [1, 4] and several
other metabolic disorders, such as other mitochondrial
disorders, peroxisomal biogenesis disorders, amino acid
metabolism disorders and urea cycle defects [7].
Germinolytic cysts are more often seen in preterm than
term-born infants and are probably the result of haemor-
rhage and subsequent lysis of the germinal matrix. In our
term-born infant the cysts were already demonstrated at
7 days of age and, therefore, were probably congenital [3,
4]. Their location in the frontal horns of the lateral
ventricles, as well as in the caudothalamic grooves, was
atypical for the evolution of germinal matrix haemorrhage.
Fig. 2 Brain MRI at 18 months
of age. Mid-sagittal T1-W spin-
echo image (a) and coronal
T2-W turbo spin-echo image (b)
demonstrate a thin callosal body
and marked atrophy of the
hemispheric white matter. Intra-
ventricular septations are also
seen in b
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Subependymal cysts have also been described in congenital
heart disease, congenital infections and several metabolic
disorders and cause primary lactic acidosis, such as
Zellweger syndrome, holocarboxylase synthetase deficien-
cy, pyruvate carboxylase deficiency, and glutaryl CoA
dehydrogenase deficiency [4]. To our knowledge, only a
few prior MRI observations of germinolytic cysts in term-
born neonates with PDH deficiency have been reported [1,
4]. In one of these infants, PDH deficiency was due to a
rarer mutation in the PDX1 gene that encodes for the E3BP
subunit of the PDH complex [4]. In another, a different
mutation in the E1-α subunit was detected, and the
subependymal cysts were interpreted as having evolved
from germinal matrix haemorrhages [1]. It is interesting to
note that different mutations leading to PDH deficiency are
associated with germinolytic cysts on neonatal neuroimag-
ing, suggesting a noncausal relationship. Although nonspe-
cific, the cysts, in combination with other neuroimaging
and clinical findings, can be a useful finding to suggest a
metabolic disorder, and specifically PDH deficiency, espe-
cially as they are mostly easily detected by cranial US or
MRI. Intraventricular septations, as seen in our patient on
follow-up imaging, have been previously reported in older
patients [3], and probably reflect the evolution of sub-
ependymal cysts.
MRS in PDH deficiency, performed with a long TE
(135 ms), usually shows an inverted lactate doublet at
1.33 ppm that is also a nonspecific finding. In our patient, a
narrow singlet at 2.37 ppm, which corresponds to pyruvate,
was not seen. This peak has been described previously in a
female neonate with PDH deficiency who died during the
neonatal period [2]. It probably reflects severe disease with
very low PDH activity levels.
The imaging differential diagnosis of the combination of
widespread white matter injury, germinolytic cysts and
dysgenesis of the corpus callosum includes oxidative
phosphorylation disorders, amino acid metabolism and urea
cycle disorders, and peroxisomal biogenesis disorders. In
these disorders findings are often associated with delayed
or absent myelination and cortical malformations [7], which
we were unable to demonstrate in our patient.
The exact mechanisms of the cerebral lesions associated
with PDH deficiency are largely unexplained. The white
matter injury may be due to reduced energy generation.
Astrocytic glutamate uptake, a protective mechanism
against excitotoxic neuronal injury, is coupled with glycol-
ysis and cellular ATP generation [8]. Impairment of cell
energy metabolism, which occurs in PDH deficiency, can
lead to irreversible excitotoxicity. However, the white
matter lesions may also be attributable to selective
susceptibility of immature oligodendrocytes to injury from
free radicals and glutamate [8].
In conclusion, we present the first description of early
MRI and MRS findings in a male neonate with PDH
deficiency. The combination of clinical findings, increased
lactate and pyruvate levels, and neuroimaging findings,
including ventriculomegaly, widespread white matter in-
volvement, callosal malformations and germinolytic cysts,
is suggestive of PDH deficiency and may lead to early
treatment and clinical decision making, before biochemical
confirmation.
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